APPLICATION
ANDA060212
TYPE
ANDA
ORIGINAL APPROVAL
1972-06-20
LATEST ACTION
2007-12-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
GRISACTINDiscontinued
GRISEOFULVIN, MICROCRYSTALLINE 500MG · TABLET · ORAL
Approval history
2007-12-07Labeling · Supplement 7AP
2007-12-07Labeling · Supplement 8AP
1991-09-03Manufacturing (CMC) · Supplement 6AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.